Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine

NCT03572491 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2000

Enrollment

OTHER_GOV

Sponsor class

Conditions

Human Influenza

Interventions

BIOLOGICAL: influenza vaccine

Sponsor

Research Institute for Biological Safety Problems

Collaborators

[object Object]
[object Object]